Skip to main content

Pardes Biosciences, Inc.

PRDSDelisted Aug 31, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001822711

Pardes Biosciences, Inc. was delisted on Aug 31, 2023; its insiders filed their last Form 4 on Aug 31, 2023; 59 institutions reported holding it in 13F filings for Q2 2023, worth $63.9M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Pardes Biosciences, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PRDS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders6867−1
Shares46.8M47.2M+340.0K (+0.7%)
Value$143.7M$87.2M−$56.5M (−39.3%)

New holders (10)

Institutions that held Pardes Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to PRDS in Q3 2022
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC212,500$393.0K0.01%
Allspring Global Investments Holdings, LLC75,519$139.0K0.00%
Ieq Capital, LLC56,672$105.0K0.00%
Jackson Square Capital, LLC26,396$49.0K0.02%
Virtu Financial LLC13,376$25.0K0.00%
SG Americas Securities, LLC10,619$20.0K0.00%
Susquehanna International Group, LLP10,535$19.0K0.00%
Russell Investments Group, Ltd.8,536$15.0K0.00%
Capital Advisors, Ltd. LLC151$00.00%
State of Wyoming50$00.00%

Sold out (11)

Institutions that held Pardes Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of PRDS in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Sio Capital Management, LLC315,564$969.0K
Point72 Asset Management, L.P.266,400$818.0K
Ikarian Capital, LLC223,934$687.0K
EcoR1 Capital, LLC200,000$614.0K
HRT Financial LP66,098$202.0K
TCG Crossover Management, LLC59,039$181.0K
D. E. Shaw & Co., Inc.57,072$175.0K
Boothbay Fund Management, LLC27,457$84.0K
Dynamic Technology Lab Private Ltd12,013$37.0K
Cubist Systematic Strategies, LLC7,800$24.0K
Penserra Capital Management LLC2,360$7.00K